[1]
|
Brito-Zerón, P., Baldini, C., Bootsma, H., et al. (2016) Sjögren Syndrome. Nature Reviews Disease Primers, 2, Article No. 16047. https://doi.org/10.1038/nrdp.2016.47
|
[2]
|
Vivino, F.B. (2017) Sjogren’s Syndrome: Clinical Aspects. Clinical Immunology, 182, 48-54.
https://doi.org/10.1016/j.clim.2017.04.005
|
[3]
|
Cafaro, G., Bursi, R., Chatzis, L.G., et al. (2021) One Year in Re-view 2021: Sjögren’s Syndrome. Clinical and Experimental Rheumatology, 39, 3-13. https://doi.org/10.55563/clinexprheumatol/eojaol
|
[4]
|
Han, J.H., Wang, J.N., Zhang, Y.L., et al. (2020) Prevalence of Monoclonal Gammopathy of Undetermined Significance in a Large Population with Annual Medical Check-ups in China. Blood Cancer Journal, 10, Article No. 34.
https://doi.org/10.1038/s41408-020-0303-8
|
[5]
|
Merlini, G. and Stone, M.J. (2006) Dangerous Small B-Cell Clones. Blood, 108, 2520-2530.
https://doi.org/10.1182/blood-2006-03-001164
|
[6]
|
孙宇. 合并高免疫球蛋白血症的原发性干燥综合征患者的临床特征的回顾性研究[D]: [硕士学位论文]. 呼和浩特: 内蒙古医科大学, 2020.
|
[7]
|
Shiboski, C.H., Shiboski, S.C., Seror, R., et al. (2017) 2016 American College of Rheumatology/European League Against Rheumatism Classifica-tion Criteria for Primary Sjögre’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis & Rheumatology, 69, 35-45.
https://doi.org/10.1002/art.39859
|
[8]
|
Kroese, F.G., Abdulahad, W.H., Haacke, E., et al. (2014) B-Cell Hyperac-tivity in Primary Sjögren’s Syndrome. Expert Review of Clinical Immunology, 10, 483-499. https://doi.org/10.1586/1744666X.2014.891439
|
[9]
|
Brito-Zerón, P., Retamozo, S., Gandía, M., et al. (2012) Monoclonal Gammopathy Related to Sjögren Syndrome: A Key Marker of Disease Prognosis and Outcomes. Journal of Autoimmunity, 39, 43-48.
https://doi.org/10.1016/j.jaut.2012.01.010
|
[10]
|
Tomi, A.L., Belkhir, R., Nocturne, G., et al. (2016) Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients with Primary Sjögren’s Syndrome. Arthritis & Rheumatology, 68, 1245-1250.
https://doi.org/10.1002/art.39534
|
[11]
|
Nishishinya, M.B., Pereda, C.A., Muñoz-Fernández, S., et al. (2015) Identi-fication of Lymphoma Predictors in Patients with Primary Sjögren’s Syndrome: A Systematic Literature Review and Meta-Analysis. Rheumatology International, 35, 17-26. https://doi.org/10.1007/s00296-014-3051-x
|
[12]
|
冯斯斯, 钟白云, 郭婧婧, 等. 原发性干燥综合征并发血液系统损害与免疫学指标相关性分析[J]. 中国现代医学杂志, 2013, 23(25): 44-46.
|
[13]
|
张毓莹. 原发性干燥综合征肾小管酸中毒和神经系统受累的临床特征研究[D]: [博士学位论文]. 北京: 北京协和医学院, 2020.
|
[14]
|
Zhao, Q., Chen, X., Hou, Y., et al. (2016) Pharmacokinetics, Pharma-codynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients with Systemic Lupus Ery-thematosus. The Journal of Clinical Pharmacology, 56, 948-959. https://doi.org/10.1002/jcph.686
|
[15]
|
江文静, 何德宁, 胡建康, 等. 泰它西普治疗中重度活动性系统性红斑狼疮的疗效及全安性观察[J]. 江西医药, 2020, 55(11): 1637-1641, 1671.
|
[16]
|
熊俊慧, 薛静, 丁振华, 等. 糖皮质激素类药物联合治疗类风湿性关节炎患者的疗效及安全性评价[J]. 中国医院药学杂志, 2016, 36(18): 1582-1585.
|
[17]
|
周永芹, 谭晓晟, 高思抗, 等. 环磷酰胺对小鼠免疫功能的影响[C]//中国免疫学会第九届全国免疫学学术大会论文集. 2014: 272-273.
|
[18]
|
Tang, S.C., Tang, A.W., Wong, S.S., et al. (2010) Long-Term Study of Mycophenolate Mofetil Treatment in IgA Nephropathy. Kidney In-ternational, 77, 543-549. https://doi.org/10.1038/ki.2009.499
|
[19]
|
夏光涛, 王霞, 吴倩, 等. 环孢素用于类风湿关节炎的治疗研究[J]. 世界临床药物, 2016, 37(3): 148-150.
|
[20]
|
张姊杰, 贾喆, 赵少贞. 他克莫司治疗干眼的作用机制和临床应用[J]. 国际眼科纵览, 2022, 46(4): 318-323.
|
[21]
|
达明莲, 邓肇达, 鲁锦玥, 等. 甲氨蝶呤与Th17/Treg细胞平衡对类风湿关节炎的作用机制研究[J]. 医学综述, 2017, 23(15): 3046-3050.
|
[22]
|
Xie, J., Fan, X., Su, Y., et al. (2022) Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects. Clinical Pharmacology in Drug Development, 11, 1273-1283. https://doi.org/10.1002/cpdd.1136
|